CPD704
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 25, 2025
Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=90 | Recruiting | Sponsor: Beijing Tide Pharmaceutical Co., Ltd
New P1 trial
1 to 1
Of
1
Go to page
1